New medicines based on compounds of marine origin
Sea4Us is a biotechnology company based in Sagres and Lisbon (Portugal). He specializes in the discovery and early development of new drugs based on novel compounds of marine origin, to address unanswered clinical conditions that require new chemical approaches and new molecular solutions.
Sea4Us has developed a platform, based on marine biology and ion channels, that enables the identification of new drugs derived from marine organisms for various unmet clinical needs that have ion channels as therapeutic targets. This drug discovery platform can be used to identify new ion channel modulators involved in different pathologies, such as chronic pain, epilepsy, diabetes, cardiac arrhythmia, hypertension, and skin diseases, among others.
The company’s activity is focused on the study of bioactivity of compounds from marine organisms, consequent biotechnological production or artificial chemical synthesis of pure bioactive compounds, and pharmaceutical development, including non-clinical and early clinical trials.
The development of new drugs and the improvement of patients’ living conditions is our main driving force.
